On June 26, Molina Healthcare rose 5.03% in regular trading, trading at $226.83/share, with turnover of $148 million. The stock extended gains following a series of positive catalysts including RBC Capital's initiation of coverage and the company's Illinois Medicaid contract win.

RBC Capital initiated coverage on June 23 with a Sector Perform rating and a $216 price target, citing a clear path to earnings growth through 2027 driven by the reversal of Florida CMS startup costs, the exit from Medicare Advantage Prescription Drug plans, and operating leverage from approximately $6 billion in new revenue. RBC's adjusted EPS estimate for 2027 stands at $9.60, broadly in line with management's outlook of at least $4.50 per share in embedded earnings.

Additionally, Molina recently won an Illinois Medicaid managed care contract covering approximately 3.1 million beneficiaries, effective January 2027 for four-and-a-half years with extension options. Multiple investment banks have also raised price targets, with UBS adjusting to $202 and Truist to $205, reflecting improving industry sentiment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)